Condition
Primary Mediastinal Large B-Cell Lymphoma-Recurrent clinical trials and research
Research outlook What's coming for Diffuse large B-cell lymphoma: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 3 Primary Mediastinal Large B-Cell Lymphoma-Recurrent clinical trials that are recruiting, at sites in 2 countries (most in United States (2), Taiwan (1)). By phase: Phase 1 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 2Countries
Newest Primary Mediastinal Large B-Cell Lymphoma-Recurrent clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Evaluating GF-CART01 for treating relapsed or refractory B-cell cancers | Phase 1 | Taipei | Recruiting | Nov 25, 2024 |
| Combining CC-99282 with Rituximab for Non-Hodgkin's Lymphoma Treatment | Phase 1 | Columbus, Ohio | Recruiting | Jan 17, 2024 |
| Combining pembrolizumab with CAR T-cell therapy for recurrent primary mediastinal large B-cell lymphoma | Phase 2 | Boston, Massachusetts and 1 other locations | Recruiting | Jul 7, 2023 |
All recruiting trials (3)
-
Evaluating GF-CART01 for treating relapsed or refractory B-cell cancers
This study is testing a new CAR T cell therapy called GF-CART01 to see if it can help adults with tough-to-treat B-cell cancers that haven't responded to other treatments.
-
Combining CC-99282 with Rituximab for Non-Hodgkin's Lymphoma Treatment
This study is testing a new combination of a pill called CC-99282 and an infusion called rituximab to see if it helps people with non-Hodgkin's lymphoma who didn't respond well to previous treatments.
-
Combining pembrolizumab with CAR T-cell therapy for recurrent primary mediastinal large B-cell lymphoma
This study is testing if adding pembrolizumab to CAR T-cell therapy can help people with recurrent primary mediastinal large B-cell lymphoma feel better and live longer.
Related topics
Quick answers
How many Primary Mediastinal Large B-Cell Lymphoma-Recurrent clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (2 trials), Taiwan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.